Patents Assigned to Guangzhou Konzern Pharmaceutical Co., Ltd.
  • Dextran for treating lung cancer
    Patent number: 8519121
    Abstract: Dextran for preparing medicine for anti-lung cancer, has repeated structure unit and molecular weight of 1.5-2.5 million Daltons. The dextran is extracted from land slug.
    Type: Grant
    Filed: June 23, 2008
    Date of Patent: August 27, 2013
    Assignee: Guangzhou Konzern Pharmaceutical Co., Ltd.
    Inventors: Jinkui Xie, Anqiang Zhang, Jianguo Cao